Enzyme vs Raydium — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Raydium trades at Rp12,557 (market cap Rp3,37T, Rp234,3M 24h volume). The key difference: Raydium is far larger — about 25124.9× Enzyme's market cap, and Raydium's supply is capped (269,3M / 555M RAY (49%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Raydium for 24 Days on average.
| MLN | RAY | |
|---|---|---|
Market Cap | Rp134,13M | Rp3,37T |
Volume (24h) | Rp104,56M | Rp234,3M |
Circulating Supply | 3,3M MLN | 269,3M / 555M RAY (49%) |
Typical Hold Time | 28 Days | 24 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Raydium (RAY) trades at Rp12,568, showing neutral technical signals with bullish moving averages but neutral oscillators. The token holds a market cap of Rp3.36T with 49% of its max supply circulating. Recent milestones include surpassing Rp1,000T in trading volume after listings on Robinhood and Revolut, and enabling tokenized SpaceX stock trading on Solana, boosting its ecosystem utility.
Outlook is cautiously optimistic due to growing exchange support and protocol innovation, but risks include high volatility and regulatory uncertainty. Key support lies at Rp11,834, with resistance at Rp12,514. Investors should monitor on-chain activity and broader crypto market trends for directional cues.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Raydium (RAY) is an automated market maker (AMM) and liquidity provider built on the Solana blockchain for the Serum decentralized exchange (DEX). Unlike any other AMMs, Raydium provides on-chain liquidity to a central limit orderbook meaning that funds deposited into Raydium are converted into limit orders which sit on Serum’s orderbooks.
Read more on RAY →